{"id":"f-8b070c46fc-377335a5-c43b-5937-b135-7a4ac40b5943","title":"Cipla Q3 net dips 57 pc YoY to Rs 676 cr","description":"New Delhi, Jan 23 (PTI) Drug maker Cipla on Friday reported a 57 per cent year-on-year dip in consolidated profit after tax to Rs 676 crore for the third quarter ended December 31, 2025, impacted by a drop in US sales","timestamp":1769165611,"category":"business","headline":"Cipla Q3 net dips 57 pc YoY to Rs 676 cr","modifiedHeadline":"Cipla Q3 net profit falls 57 percent.","subCategories":["scid_4d81caea"],"region":"IN","bundleMetaData":{"bundleId":"7b48871c-c993-4956-b43d-6f46f8e1b036","bundleTitle":"Today In India","cardData":null},"iabCategoryId":"53","fcSummary":"cipla's third-quarter profit after tax fell 57% to rs 676 crore, primarily due to a 22% drop in us sales. despite a slight increase in total income to rs 7,074 crore, the company's north american market performance significantly impacted its financial results.","summary":"Cipla's Q3 profit plunges 57% to Rs 676 crore due to a significant drop in US sales.","ctaUrl":"https://trends.glance.com/newz/India_News/IN/en/pti/f-8b070c46fc-377335a5-c43b-5937-b135-7a4ac40b5943","sourceUrl":"http://www.ptinews.com","bannerImage":"https://g-mob.glance-cdn.com/public/dynamic/720x1280/1ca9d3ab0f66c53a049201102a27871ccc5946c4.webp","content":"

New Delhi, Jan 23 (PTI) Drug maker Cipla on Friday reported a 57 per cent year-on-year dip in consolidated profit after tax to Rs 676 crore for the third quarter ended December 31, 2025, impacted by a drop

\n\n

in US sales.

The Mumbai-based firm posted a profit after tax at Rs 1,571 crore for the October-December quarter last year.

Total income from operations rose to Rs 7,074 crore for the period under review as against Rs 7,073 crore in the year-ago period, Cipla said in a regulatory filing.

\n\n

The company's North America sales dropped 22 per cent to Rs 1,485 crore during the quarter as compared with Rs 1,906 crore in the year-ago period.

Cipla shares were trading 3.76 per cent down at Rs 1,319.95 apiece on BSE. PTI MSS MR

\n\n

","readDurationInMinutes":"1","author":{"name":"PTI","logo":"https://glance-mob.glance-cdn.com/public/bubble/jpeg/b4428283-3bff-45db-a5fa-15dccca89081.jpeg"},"ism":false,"analyticsResponses":[],"pointerSummary":["Cipla Q3 profit down 57% to Rs 676 crore.","US sales drop 22% impacting profit.","Total income slightly up to Rs 7,074 crore."],"tags":["Cipla","Q3Results","FinancialResults","NetProfit","USSales","Pharmaceuticals","Mumbai","BSE","StockMarket","CiplaShares"],"redirectionEnabled":false,"consent":true}

Cipla Q3 net dips 57 pc YoY to Rs 676 cr

SUMMARY